For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260205:nRSE9103Ra&default-theme=true
RNS Number : 9103R St. James's Place PLC 05 February 2026
Directorate Change
St. James's Place plc is pleased to announce the appointment of Evelyn Bourke
as an Independent Non-executive Director with effect from 1 March 2026. Upon
appointment, Evelyn will be a member of the Group Audit Committee and Group
Remuneration Committee.
Evelyn has wide-ranging senior leadership experience gained during her
executive career with companies including Friends Life plc, Standard Life,
Chase de Vere and Tillinghast Towers Perrin (now part of WTW). Her most recent
executive role was as group CEO at Bupa from July 2016 to December 2020.
Previous non-executive positions held by Evelyn include directorships at AJ
Bell plc and IFG Group plc. Evelyn is a qualified actuary and holds an MBA
from London Business School.
Evelyn is currently a non-executive director of Marks & Spencer Group plc
and chairs their Audit and Risk committee. She is also non-executive director
at Admiral Group plc and is a member of their Audit committee.
Paul Manduca, Chair of St. James's Place plc, said: "I am delighted to
announce Evelyn's appointment to the Board. Evelyn brings broad and diverse
experience in business transformation and strategy leadership as well as
highly relevant financial and governance expertise. We look forward to her
joining the Board in March."
There is no other information regarding Evelyn Bourke's appointment to be
disclosed under paragraph 6.4.8R of the UK Listing Rules.
Ends
Enquiries:
Hugh Taylor, Director - Investor
Relations
Tel: 07818 075 143
Angela Warburton, Director -
Communications
Tel: 07442 479 542
Brunswick
Group:
Tel: 020 7404 5959
Ellis Murphy
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAFELFBQLLXBBL
Copyright 2019 Regulatory News Service, all rights reserved